Emergent BioSolutions, operator of troubled Baltimore facility, ends contract with federal government to produce COVID vaccines, respond to pandemic

The program, created under President Barack Obama’s tenure, is run through the U.S. Department of Health and Human Services, which committed to building new facilities, training more staff and providing surge capacity and advance manufacturing of biopharmaceutical products and therapeutics for “emerging infectious disease, pandemic influenza, and currently known or unknown threats.”

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *